Buy Neoton vials 1 g, 4 pcs
  • Buy Neoton vials 1 g, 4 pcs

Creatine Phosphate

Alpha wasserman
1755 Items
2019-09-19
Dosage form
Brand & Manufacturer
Package Size
$224.19
Quantity
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Neotone - a drug that improves the metabolism of the myocardium and muscle tissue. The chemical structure is similar to macroergic endogenous phosphocreatine. Slows down the process of destruction of the sarcolemma of ischemic cardiomyocytes and myocytes, provides intracellular transport of energy. By improving microcirculation, the drug reduces the size of the area of ​​necrosis and ischemia. With ischemia and post-ischemic reperfusion, it causes an antiarrhythmic effect, which is associated with a decrease in the ectopic activity of the ventricles and preservation of the physiological function of cells of Purkinje fibers.

Indications

- acute myocardial infarction;
- chronic heart failure;
- intraoperative myocardial ischemia;
- intraoperative limb ischemia;
- acute violation of cerebral circulation;
- in sports medicine: to prevent the development of the syndrome of physical overvoltage and improve adaptation to extreme physical exertion.

Composition

1 bottle contains phosphocreatine 1 g.

No customer reviews for the moment.

Write your review

Write your review

Creatine Phosphate

Dosage and Administration

Withacute myocardial infarction On the 1st day, 2-4 g intravenously are administered, followed by drip infusion of 8-16 g in 200 ml of 5% glucose solution for 2 hours. times / day On the 3rd day, 2 g / d drip is prescribed 2 times / day.
If necessary, a course of drug infusion of 2 g 2 times / day can be performed for 6 days.
Withchronic heart failure administered in / in the drip 1-2 g 2 times / day for 10-14 days.
Withintraoperative myocardial ischemia the drug is administered as part of a conventional cardioplegic solution in the amount of 3 g per 1 liter. Neotone is added to the solution immediately prior to administration. It is recommended to conduct a course of infusion of the drug 2 g 2 times / day for 3-5 days prior to surgery, and within 1-2 days after surgery.
With the possibility of developmentintraoperative limb ischemia It is recommended to introduce 2-4 g of the drug intravenously before the operation with subsequent infusion of 8-10 g in a 5% glucose solution during the operation and the reperfusion period.

Adverse reactions

Decrease in blood pressure (with a rapid on / in the introduction).

Contraindications

Hypersensitivity to the drug.

Drug interactions

When used as part of a combination therapy, Neoton contributes to the effectiveness of antiarrhythmic, antianginal drugs, as well as drugs that have a positive effect on the myocardial inotropic function.

Pregnancy and Lactation

Data on the safety and efficacy of the drug Neoton during periods of pregnancy and lactation (breastfeeding) are not provided.

Special instructions

The drug should be administered as soon as possible after the onset of signs of ischemia, which provides a more favorable prognosis of the disease.
Neotone is not used for emergency correction of disorders of the heart.

  • Brand name: Neoton
  • Active ingredient: Phosphocreatine
  • Dosage form: Lyophilized powder for preparing a solution for infusion.
  • Manufacturer: Alpha wasserman
  • Country of Origin: Italy

Studies and clinical trials of Creatine Phosphate (Click to expand)

  1. Action of Aqueous Extracts of Bearberry and Cowberry Leaves and Wild Camomile and Pineapple-weed Flowers on Escherichia coli Surface Structures
  2. Simultaneous determination of myocardial creatine phosphate and adenine nucleotides by reversed-phase HPLC
  3. Histochemical studies of alkaline phosphatases in the tissues of the rat using frozen sections. II. Substrate specificity of enzymes hydrolyzing adenosine-triphosphate, muscle- and yeast-adenylic acids, and creatine-phosphate at high pH; the histochemical demonstration of myosin ATP-ase
  4. Diffusion coefficients of atp and creatine phosphate in isolated muscle: pulsed gradient 31p nmr of small biological samples
  5. Extraction and Assay of Creatine Phosphate, Purine, and Pyridine Nucleotides in Cardiac Tissue by Reversed-Phase High-Performance Liquid Chromatography
  6. Enzymic determination of inorganic phosphate in the presence of creatine phosphate
  7. Three-step preparation and purification of phosphorus-33-labeled creatine phosphate of high specific activity
  8. Chemically coupled spectrophotometric assays based on flow injection analysis: Determination of nitrogenase by assays for creatine, ammonia, hydrazine, phosphate, and dithionite
  9. Determiantion of creatine phosphate levels in brain tissue by isocratic reverse-phase, ion-paired high-performance liquid chromatography
  10. The creatine phosphate energy shuttle—The molecular asymmetry of a “pool”
  11. Computerized calculation of in vitro generation of ATP and creatine phosphate induced by respiration in human muscle mitochondria
  12. High-performance liquid chromatographic method for the simultaneous determination of myocardial creatine phosphate and adenosine nucleotides
  13. Isocratic high-performance liquid chromatographic analysis of myocardial creatine phosphate and adenine nucleotides
  14. Simultaneous determination of myocardial nucleotides, nucleosides, purine bases and creatine phosphate by ion-pair high-performance liquid chromatography
  15. Potassium contractures and creatine phosphate breakdown in frog muscle
  16. An improvement in the method for separation of certain nucleosides nucleotide and creatine phosphate.
  17. Novel dual-wavelength monitoring approach for the improved rapid separation and estimation of adenine nucleotides and creatine phosphate bu high-performance liquid chromatography
  18. A sensitive and rapid method for separating adenine nucleotides and creatine phosphate by ion-pair reversed-phase high-performance liquid chromatography
  19. Simultaneous quantification of myocardial adenine nucleotides and creatine phosphate by ion-pair reversed-phase high-performance liquid chromatography
  20. Interactions between vanadyl(IV) cation and the system creatine, creatine phosphate and creatinine
  21. Muscle creatine phosphate in gyrate atrophy of the choroid and retina with hyperornithinaemia–clues to pathogenesis
  22. Preincubation with Creatine Enhances Levels of Creatine Phosphate and Prevents Anoxic Damage in Rat Hippocampal Slices
  23. ATP, creatine phosphate, and mechanical activity in rainbow trout myocardium under inhibition of glycolysis and cell respiration
  24. The effects of phosphate administration on phosphoryl-creatine, glycogen, and lactate levels in animal muscle
  25. Effect of adaptation to repeated stress on cardiac function repair and creatine phosphate level restoration following total ischemia (31P-NMR investigation)

Customers who bought this product also bought:

8 other products in the same category:

arrow_upward